[STUDIES OF THE ANTIHYPOXIC AND ANTIAMNESTIC EFFECTS OF MELATONIN IN ANIMALS]

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Hypoxia and amnesia pose significant physiological challenges.
• Current treatments for hypoxia and amnesia have limitations.
• Melatonin's potential neuroprotective roles require further investigation.

Purpose of the Study:

• To evaluate the antihypoxic and antiamnestic efficacy of melatonin.
• To compare melatonin's effects with established agents like amtisol and pyracetame.
• To elucidate the cellular mechanisms underlying melatonin's neuroprotective actions.

Main Methods:

• Acute hypoxia models in mice (normobaric, hypobaric, hemic, histotaxic).
• Amnesia models including scopolamine-induced and hypoxia-induced amnesia.
• Electrophysiological recordings in rat hippocampus (Schaffer collateral-CA1 synapse).
• Pharmacological blockade of melatonin receptors (MT1 and MT2) using lusindol.

Main Results:

• Melatonin significantly improved outcomes in various hypoxia and amnesia models, exceeding the efficacy of amtisol and pyracetame.
• Dose-dependent enhancement of antihypoxic and antiamnestic effects was observed with increasing melatonin doses (1-20 mg/kg).
• Melatonin inhibited neuronal responses in the hippocampus via MT1 and MT2 receptor stimulation, with higher concentrations (0.5-5 mM) showing greater inhibition.

Conclusions:

• Melatonin exhibits potent antihypoxic and antiamnestic properties.
• Melatonin's neuroprotective effects are mediated through MT1 and MT2 receptor activation in the hippocampus.
• Melatonin represents a promising therapeutic agent for conditions involving hypoxia and memory impairment.